SNY

Sanofi ADS
D

SNY

49.025
USD
0.29
(0.60%)
Market Closed
Volume
71,091
EPS
4
Div Yield
4.54
P/E
16
Market Cap
119,569,796,133
Related Instruments
ABBV
ABBV
3.220
(1.60%)
204.680 USD
AZN
AZN
0.520
(0.67%)
78.480 USD
BMY
BMY
-0.025
(-0.05%)
47.820 USD
GILD
GILD
-1.140
(-0.95%)
119.000 USD
GSK
GSK
0.070
(0.18%)
39.220 USD
LLY
LLY
23.95
(3.63%)
684.45 USD
MRK
MRK
0.045
(0.05%)
82.750 USD
NVS
NVS
0.890
(0.73%)
122.130 USD
PFE
PFE
-0.045
(-0.18%)
25.100 USD
REGN
REGN
4.35
(0.77%)
565.90 USD
R
ROG
-1.363
(-1.75%)
76.620 USD
More
News

Title: Sanofi ADS

Sector: Healthcare
Industry: Drug Manufacturers - General
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.